Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance

Journal of Biological Chemistry

Volumn 289, Issue 15, 2014, Pages 10431-10444

  Wallez, Yann ^a,c   Riedl, Stefan J ^a   Pasquale, Elena B ^a,b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION REACTIONS; COMPLEX NETWORKS; DISEASES; PROTEINS; SIGNALING;

ASSOCIATED SIGNALING; C-TERMINAL DOMAINS; DOMAIN-CONTAINING PROTEINS; MCF-7 BREAST CANCER CELLS; PATIENT SURVIVALS; REGULATORY PROTEIN; SCAFFOLDING PROTEINS; SIGNALING NETWORKS;

SCAFFOLDS (BIOLOGY);

ANTIESTROGEN; BREAST CANCER ANTIESTROGEN RESISTANCE PROTEIN 3; CRK ASSOCIATED SUBSTRATE PROTEIN; CYTOPLASM PROTEIN; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NOVEL SH2 CONTAINING PROTEIN 3; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15; REGULATOR PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RESISTANCE; CELL STRAIN MCF 7; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANTICANCER DRUG; BREAST CANCER; CANCER; DRUG RESISTANCE; ERK1/2; MAP KINASES (MAPKS); MESENCHYMAL PHENOTYPE; NSP3; PEA15; PROTEIN-PROTEIN INTERACTIONS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST NEOPLASMS; CRK-ASSOCIATED SUBSTRATE PROTEIN; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LENTIVIRUS; MCF-7 CELLS; MICROSCOPY, FLUORESCENCE; MUTATION; PHENOTYPE; PHOSPHORYLATION; PLASMIDS; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

EID: 84898670965     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.541839     Document Type: Article

References (72)

1. Riggins, R. B., Schrecengost, R. S., Guerrero, M. S., and Bouton, A. H. (2007) Pathways to tamoxifen resistance. Cancer letters 256, 1-24
2. Musgrove, E. A., and Sutherland, R. L. (2009) Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer 9, 631-643
3. Brinkman, A., van der Flier, S., Kok, E. M., and Dorssers, L. C. (2000) BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells. J. Natl. Cancer Inst. 92, 112-120
4. van der Flier, S., Chan, C. M., Brinkman, A., Smid, M., Johnston, S. R., Dorssers, L. C., and Dowsett, M. (2000) BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas. Int. J. Cancer 89, 465-468
5. van der Flier, S., Brinkman, A., Look, M. P., Kok, E. M., Meijer-van Gelder, M. E., Klijn, J. G., Dorssers, L. C., and Foekens, J. A. (2000) Bcar1/p130Cas protein and primary breast cancer. Prognosis and response to tamoxifen treatment. J. Natl. Cancer Inst. 92, 120-127
6. Brábek, J., Constancio, S. S., Shin, N. Y., Pozzi, A., Weaver, A. M., and Hanks, S. K. (2004) CAS promotes invasiveness of Src-transformed cells. Oncogene 23, 7406-7415
7. Ta, H. Q., Thomas, K. S., Schrecengost, R. S., and Bouton, A. H. (2008) A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Res. 68, 8796-8804
8. Wendt, M. K., Smith, J. A., and Schiemann, W. P. (2009) p130Cas is required for mammary tumor growth and transforming growth factor β-mediated metastasis through regulation of Smad2/3 activity. J. Biol. Chem. 284, 34145-34156
9. Cunningham-Edmondson, A. C., and Hanks, S. K. (2009) p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells. Breast Cancer Res. Treat. 2009, 39-52
10. Soni, S., Lin, B. T., August, A., Nicholson, R. I., and Kirsch, K. H. (2009) Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells. J. Cell Biochem. 107, 364-375
11. Wallez, Y., Mace, P. D., Pasquale, E. B., and Riedl, S. J. (2012) NSP-CAS Protein Complexes. Emerging Signaling Modules in Cancer. Genes Cancer 3, 382-393
12. Tikhmyanova, N., Little, J. L., and Golemis, E. A. (2010) CAS proteins in normal and pathological cell growth control. Cell Mol. Life Sci. 67, 1025-1048
13. Tornillo, G., Elia, A. R., Castellano, I., Spadaro, M., Bernabei, P., Bisaro, B., Camacho-Leal Mdel, P., Pincini, A., Provero, P., Sapino, A., Turco, E., Defilippi, P., and Cabodi, S. (2013) p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity. Stem Cells 31, 1422-1433
14. Hochgräfe, F., Zhang, L., O'Toole, S. A., Browne, B. C., Pinese, M., Porta Cubas, A., Lehrbach, G. M., Croucher, D. R., Rickwood, D., Boulghourjian, A., Shearer, R., Nair, R., Swarbrick, A., Faratian, D., Mullen, P., Harrison, D. J., Biankin, A. V., Sutherland, R. L., Raftery, M. J., and Daly, R. J. (2010) Tyrosine phosphorylation profiling reveals the signaling network characteristics of basal breast cancer cells. Cancer Res. 70, 9391-9401
15. Cabodi, S., Tinnirello, A., Di Stefano, P., Bisarò, B., Ambrosino, E., Castellano, I., Sapino, A., Arisio, R., Cavallo, F., Forni, G., Glukhova, M., Silengo, L., Altruda, F., Turco, E., Tarone, G., and Defilippi, P. (2006) p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res. 66, 4672-4680
16. Cabodi, S., Tinnirello, A., Bisaro, B., Tornillo, G., del Pilar Camacho-Leal, M., Forni, G., Cojoca, R., Iezzi, M., Amici, A., Montani, M., Eva, A., Di Stefano, P., Muthuswamy, S. K., Tarone, G., Turco, E., and Defilippi, P. (2010) p130Cas is an essential transducer element in ErbB2 transformation. FASEB J. 24, 3796-3808
17. Pylayeva, Y., Gillen, K. M., Gerald, W., Beggs, H. E., Reichardt, L. F., and Giancotti, F. G. (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J. Clin. Invest. 119, 252-266
18. van der Flier, S., van der Kwast, T. H., Claassen, C. J., Timmermans, M., Brinkman, A., Henzen-Logmans, S. C., Foekens, J. A., and Dorssers, L. C. (2001) Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue. Int. J. Biol. Markers 16, 172-178
19. Dorssers, L. C., Grebenchtchikov, N., Brinkman, A., Look, M. P., van Broekhoven, S. P., de Jong, D., Peters, H. A., Portengen, H., Meijer-van Gelder, M. E., Klijn, J. G., van Tienoven, D. T., Geurts-Moespot, A., Span, P. N., Foekens, J. A., and Sweep, F. C. (2004) The prognostic value of BCAR1 in patients with primary breast cancer. Clin. Cancer Res. 10, 6194-6202
20. Defilippi, P., Di Stefano, P., and Cabodi, S. (2006) p130Cas. A versatile scaffold in signaling networks. Trends Cell Biol. 16, 257-263
21. Feller, S. M. (1998) Physiological signals and oncogenesis mediated through Crk family adapter proteins. J. Cell. Physiol. 177, 535-552
22. Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., and Cheresh, D. A. (1998) CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J. Cell Biol. 140, 961-972
23. Near, R. I., Zhang, Y., Makkinje, A., Vanden Borre, P., and Lerner, A. (2007) AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation, and altered breast cancer cell morphology. J. Cell Physiol. 212, 655-665
24. van Agthoven, T., van Agthoven, T. L., Dekker, A., van der Spek, P. J., Vreede, L., and Dorssers, L. C. (1998) Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 17, 2799-2808
25. Lu, Y., Brush, J., and Stewart, T. A. (1999) NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c- Jun N-terminal kinase/stress-activated protein kinase signaling pathway. J. Biol. Chem. 274, 10047-10052
26. Cai, D., Clayton, L. K., Smolyar, A., and Lerner, A. (1999) AND-34, a novel p130Cas-binding thymic stromal cell protein regulated by adhesion and inflammatory cytokines. J. Immunol. 163, 2104-2112
27. Felekkis, K. N., Narsimhan, R. P., Near, R., Castro, A. F., Zheng, Y., Quilliam, L. A., and Lerner, A. (2005) AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner. Mol. Cancer Res. 3, 32-41
28. Cai, D., Iyer, A., Felekkis, K. N., Near, R. I., Luo, Z., Chernoff, J., Albanese, C., Pestell, R. G., and Lerner, A. (2003) AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res. 63, 6802-6808
29. Makkinje, A., Near, R. I., Infusini, G., Vanden Borre, P., Bloom, A., Cai, D., Costello, C. E., and Lerner, A. (2009) AND-34/BCAR3 regulates adhesiondependent p130Cas serine phosphorylation and breast cancer cell growth pattern. Cell. Signal. 21, 1423-1435
30. Riggins, R. B., Quilliam, L. A., and Bouton, A. H. (2003) Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/ BCAR3. J. Biol. Chem. 278, 28264-28273
31. Schrecengost, R. S., Riggins, R. B., Thomas, K. S., Guerrero, M. S., and Bouton, A. H. (2007) Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res. 67, 6174-6182
32. Schuh, N. R., Guerrero, M. S., Schrecengost, R. S., and Bouton, A. H. (2010) BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling. J. Biol. Chem. 285, 2309-2317
33. Wilson, A. L., Schrecengost, R. S., Guerrero, M. S., Thomas, K. S., and Bouton, A. H. (2013) Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. PLoS ONE 8, e65678
34. Dodelet, V. C., Pazzagli, C., Zisch, A. H., Hauser, C. A., and Pasquale, E. B. (1999)Anovel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. J. Biol. Chem. 274, 31941-31946
35. Sakakibara, A., and Hattori, S. (2000) Chat, a Cas/HEF1-associated adaptor protein that integrates multiple signaling pathways. J. Biol. Chem. 275, 6404-6410
36. Mace, P. D., Wallez, Y., Dobaczewska, M. K., Lee, J. J., Robinson, H., Pasquale, E. B., and Riedl, S. J. (2011) NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling. Nat. Struct. Mol. Biol. 18, 1381-1387
37. Sun, G., Cheng, S. Y., Chen, M., Lim, C. J., and Pallen, C. J. (2012) Protein tyrosine phosphatase α phosphotyrosyl 789 binds BCAR3 to position Cas for activation at integrin-mediated focal adhesions. Mol. Cell. Biol. 32, 3776-3789
38. Garron, M. L., Arsenieva, D., Zhong, J., Bloom, A. B., Lerner, A., O'Neill, G. M., and Arold, S. T. (2009) Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance. J. Mol. Biol. 386, 190-203
39. Vanden Borre, P., Near, R. I., Makkinje, A., Mostoslavsky, G., and Lerner, A. (2011) BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas. Cell. Signal. 23, 1030-1040
40. Roselli, S., Wallez, Y., Wang, L., Vervoort, V., and Pasquale, E. B. (2010) The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas. Cell. Signal. 22, 1745-1752
41. Patwardhan, P., Shen, Y., Goldberg, G. S., and Miller, W. T. (2006) Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth. J. Biol. Chem. 281, 20689-20697
42. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., and Hirai, H. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation- dependent manner. EMBO J. 13, 3748-3756
43. Fonseca, P. M., Shin, N. Y., Brábek, J., Ryzhova, L., Wu, J., and Hanks, S. K. (2004) Regulation and localization of CAS substrate domain tyrosine phosphorylation. Cell. Signal. 16, 621-629
44. Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., Concannon, K. F., Donaldson, M. C., Sequist, L. V., Brachtel, E., Sgroi, D., Baselga, J., Ramaswamy, S., Toner, M., Haber, D. A., and Maheswaran, S. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584
45. Lacroix, M., and Leclercq, G. (2004) Relevance of breast cancer cell lines as models for breast tumours. An update. Breast Cancer Res. Treat. 83, 249-289
46. Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J. P., Tong, F., Speed, T., Spellman, P. T., DeVries, S., Lapuk, A., Wang, N. J., Kuo, W. L., Stilwell, J. L., Pinkel, D., Albertson, D. G., Waldman, F. M., McCormick, F., Dickson, R. B., Johnson, M. D., Lippman, M., Ethier, S., Gazdar, A., and Gray, J. W. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515-527
47. Hiscox, S., Morgan, L., Barrow, D., Dutkowskil, C., Wakeling, A., and Nicholson, R. I. (2004) Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype. Inhibition by gefitinib ("Iressa," ZD1839). Clin. Exp. Metastasis 21, 201-212
48. Vervoort, V. S., Roselli, S., Oshima, R. G., and Pasquale, E. B. (2007) Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling. Gene 391, 161-170
49. Regelmann, A. G., Danzl, N. M., Wanjalla, C., and Alexandropoulos, K. (2006) The hematopoietic isoform of Cas-Hef1-associated signal transducer regulates chemokine-induced inside-out signaling and T cell trafficking. Immunity 25, 907-918
50. Dail, M., Kalo, M. S., Seddon, J. A., Côté, J. F., Vuori, K., and Pasquale, E. B. (2004) SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein cas but not with Ras GTPases. J. Biol. Chem. 279, 41892-41902
51. Makkinje, A., Vanden Borre, P., Near, R. I., Patel, P. S., and Lerner, A. (2012) Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas). J. Biol. Chem. 287, 27703-27714
52. Cowell, L. N., Graham, J. D., Bouton, A. H., Clarke, C. L., and O'Neill, G. M. (2006) Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway. Oncogene 25, 7597-7607
53. Formstecher, E., Ramos, J. W., Fauquet, M., Calderwood, D. A., Hsieh, J. C., Canton, B., Nguyen, X. T., Barnier, J. V., Camonis, J., Ginsberg, M. H., and Chneiweiss, H. (2001) PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1, 239-250
54. Bartholomeusz, C., Gonzalez-Angulo, A. M., Kazansky, A., Krishnamurthy, S., Liu, P., Yuan, L. X., Yamasaki, F., Liu, S., Hayashi, N., Zhang, D., Esteva, F. J., Hortobagyi, G. N., and Ueno, N. T. (2010) PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin. Cancer Res. 16, 1802-1811
55. Mace, P. D., Wallez, Y., Egger, M. F., Dobaczewska, M. K., Robinson, H., Pasquale, E. B., and Riedl, S. J. (2013) Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat. Commun. 4, 1681
56. Glading, A., Koziol, J. A., Krueger, J., and Ginsberg, M. H. (2007) PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res. 67, 1536-1544
57. Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., and Schultz, N. (2012) The cBio cancer genomics portal. An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404
58. Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., Cerami, E., Sander, C., and Schultz, N. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1
59. Riggins, R. B., Thomas, K. S., Ta, H. Q., Wen, J., Davis, R. J., Schuh, N. R., Donelan, S. S., Owen, K. A., Gibson, M. A., Shupnik, M. A., Silva, C. M., Parsons, S. J., Clarke, R., and Bouton, A. H. (2006) Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res. 66, 7007-7015
60. Felekkis, K., Quilliam, L. A., and Lerner, A. (2006) Characterization of AND-34 function and signaling. Methods Enzymol. 407, 55-63
61. Brinkman, A., de Jong, D., Tuinman, S., Azaouagh, N., van Agthoven, T., and Dorssers, L. C. (2010) The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells. Breast Cancer Res. Treat. 120, 401-408
62. Van Agthoven, T., Godinho, M. F., Wulfkuhle, J. D., Petricoin, E. F., 3rd, and Dorssers, L. C. (2012) Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines. Int. J. Cancer 131, 1998-2007
63. Gee, J. M., Robertson, J. F., Ellis, I. O., and Nicholson, R. I. (2001) Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int. J. Cancer 95, 247-254
64. Bartholomeusz, C., Gonzalez-Angulo, A. M., Liu, P., Hayashi, N., Lluch, A., Ferrer-Lozano, J., and Hortobágyi, G. N. (2012) High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients. Oncologist 17, 766-774
65. Cabodi, S., Moro, L., Baj, G., Smeriglio, M., Di Stefano, P., Gippone, S., Surico, N., Silengo, L., Turco, E., Tarone, G., and Defilippi, P. (2004) p130Cas interacts with estrogen receptor α and modulates nongenomic estrogen signaling in breast cancer cells. J. Cell Sci. 117, 1603-1611
66. Kumbrink, J., and Kirsch, K. H. (2012) Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2. Neoplasia 14, 108-120
67. Fiory, F., Formisano, P., Perruolo, G., and Beguinot, F. (2009) Frontiers. PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 297, E592-E601
68. Stassi, G., Garofalo, M., Zerilli, M., Ricci-Vitiani, L., Zanca, C., Todaro, M., Aragona, F., Limite, G., Petrella, G., and Condorelli, G. (2005) PED mediates AKT-dependent chemoresistance in human breast cancer cells. Cancer Res. 65, 6668-6675
69. Condorelli, G., Vigliotta, G., Cafieri, A., Trencia, A., Andalò, P., Oriente, F., Miele, C., Caruso, M., Formisano, P., and Beguinot, F. (1999) PED/PEA-An anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18, 4409-4415
70. Shah, A. N., and Gallick, G. E. (2007) Src, chemoresistance and epithelial to mesenchymal transition. Are they related? Anticancer Drugs 18, 371-375
71. Brábek, J., Constancio, S. S., Siesser, P. F., Shin, N. Y., Pozzi, A., and Hanks, S. K. (2005) Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol. Cancer Res. 3, 307-315
72. Browne, C. D., Hoefer, M. M., Chintalapati, S. K., Cato, M. H., Wallez, Y., Ostertag, D. V., Pasquale, E. B., and Rickert, R. C. (2010) SHEP1 partners with CasL to promote marginal zone B-cell maturation. Proc. Natl. Acad. Sci. U.S.A. 107, 18944-18949